EE798 Evaluating the Potential Health and Economic Impact of V116, an Adult Specific 21-Valent Pneumococcal Conjugate Vaccine, on Invasive Pneumococcal Disease in Germany
Abstract
Authors
M Simuzingili Z Yi M de Lepper N Cossrow KD Johnson K. Owusu-Edusei